Variant report
Variant | esv3464537 |
---|---|
Chromosome Location | chr4:130064302-130070200 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:91)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr4:130066502-130066850 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr4:130067863-130068063 | K562 | blood: | n/a | n/a |
3 | BHLHE40 | chr4:130066166-130066205 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr4:130067703-130067942 | K562 | blood: | n/a | chr4:130067817-130067830 |
5 | CEBPB | chr4:130066150-130066401 | K562 | blood: | n/a | n/a |
6 | CHD2 | chr4:130066224-130066250 | K562 | blood: | n/a | n/a |
7 | CTCF | chr4:130067940-130068090 | HepG2 | liver: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
8 | CTCF | chr4:130068200-130068350 | GM12864 | blood: | n/a | n/a |
9 | CTCF | chr4:130067940-130068090 | BE2_C | brain: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
10 | CTCF | chr4:130067917-130068084 | K562 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
11 | CTCF | chr4:130067900-130068050 | HBMEC | blood vessel: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
12 | CTCF | chr4:130067900-130068050 | HRE | kidney: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
13 | CTCF | chr4:130067900-130068050 | GM12873 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
14 | CTCF | chr4:130067960-130068110 | RPTEC | kidney: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
15 | CTCF | chr4:130067987-130068049 | HUVEC | blood vessel: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
16 | CTCF | chr4:130067891-130068063 | HepG2 | liver: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
17 | CTCF | chr4:130067920-130068070 | HEK293 | kidney: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
18 | CTCF | chr4:130067860-130068010 | HCT-116 | colon: | n/a | n/a |
19 | CTCF | chr4:130067954-130068034 | GM13977 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
20 | CTCF | chr4:130067920-130068070 | GM06990 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
21 | CTCF | chr4:130067923-130068067 | HepG2 | liver: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
22 | CTCF | chr4:130067920-130068070 | GM12875 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
23 | CTCF | chr4:130067981-130068022 | GM12878 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
24 | CTCF | chr4:130067880-130068030 | Caco-2 | colon: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
25 | CTCF | chr4:130067940-130068090 | HRE | kidney: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
26 | CTCF | chr4:130067800-130067950 | BE2_C | brain: | n/a | n/a |
27 | CTCF | chr4:130067860-130068010 | GM06990 | blood: | n/a | n/a |
28 | CTCF | chr4:130067940-130068090 | HMF | breast: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
29 | CTCF | chr4:130067860-130068010 | HCFaa | heart: | n/a | n/a |
30 | CTCF | chr4:130067818-130068153 | K562 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
31 | CTCF | chr4:130067100-130067250 | K562 | blood: | n/a | n/a |
32 | CTCF | chr4:130067980-130068130 | RPTEC | kidney: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
33 | CTCF | chr4:130067080-130067230 | HepG2 | liver: | n/a | n/a |
34 | CTCF | chr4:130067900-130068050 | SK-N-SH_RA | brain: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
35 | CTCF | chr4:130068020-130068170 | Caco-2 | colon: | n/a | n/a |
36 | CTCF | chr4:130067137-130067193 | K562 | blood: | n/a | n/a |
37 | CTCF | chr4:130067880-130068030 | SK-N-SH_RA | brain: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
38 | CTCF | chr4:130067880-130068030 | K562 | blood: | n/a | chr4:130067998-130068014 chr4:130067999-130068020 chr4:130067997-130068015 |
39 | CTCF | chr4:130067060-130067210 | HCPEpiC | choroid plexus: | n/a | n/a |
40 | CTCFL | chr4:130067927-130068047 | K562 | blood: | n/a | chr4:130068004-130068013 |
41 | CUX1 | chr4:130066828-130066831 | K562 | blood: | n/a | n/a |
42 | CUX1 | chr4:130065874-130066398 | K562 | blood: | n/a | n/a |
43 | CUX1 | chr4:130069885-130069888 | GM12878 | blood: | n/a | n/a |
44 | E2F6 | chr4:130066090-130066219 | K562 | blood: | n/a | n/a |
45 | E2F6 | chr4:130067051-130067235 | K562 | blood: | n/a | n/a |
46 | EP300 | chr4:130065926-130066114 | K562 | blood: | n/a | n/a |
47 | EP300 | chr4:130067497-130067695 | K562 | blood: | n/a | n/a |
48 | EP300 | chr4:130067094-130067225 | K562 | blood: | n/a | n/a |
49 | FOS | chr4:130066612-130066874 | HUVEC | blood vessel: | n/a | chr4:130066717-130066728 |
50 | GATA2 | chr4:130065758-130066085 | HUVEC | blood vessel: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:130061469..130063287-chr4:130063449..130064968,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZSWIM5P3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183433380 | chr4:130064389-130064390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187913095 | chr4:130064416-130064417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539968486 | chr4:130064433-130064434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551561170 | chr4:130064440-130064441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs61168864 | chr4:130064466-130064467 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs368728929 | chr4:130064482-130064483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574796928 | chr4:130064635-130064636 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs537066494 | chr4:130064668-130064669 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs555702210 | chr4:130064754-130064755 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs573995516 | chr4:130064800-130064801 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs576096728 | chr4:130064801-130064802 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs567560323 | chr4:130064809-130064810 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs397730791 | chr4:130064810-130064811 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs577796632 | chr4:130064811-130064812 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs115443443 | chr4:130064812-130064813 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs534968414 | chr4:130064817-130064818 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs148749762 | chr4:130064831-130064832 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs1709422 | chr4:130064878-130064879 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs542261799 | chr4:130064933-130064934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560828052 | chr4:130064978-130064979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73848938 | chr4:130065087-130065088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs193181687 | chr4:130065088-130065089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565101824 | chr4:130065110-130065111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563676023 | chr4:130065152-130065153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146851065 | chr4:130065208-130065209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550713085 | chr4:130065227-130065228 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570073195 | chr4:130065359-130065360 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs183317757 | chr4:130065383-130065384 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs552547321 | chr4:130065396-130065397 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs371479451 | chr4:130065404-130065405 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs368573608 | chr4:130065413-130065414 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs548974667 | chr4:130065436-130065437 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs76959133 | chr4:130065515-130065516 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs535014046 | chr4:130065527-130065528 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs553237476 | chr4:130065540-130065541 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs140693684 | chr4:130065576-130065577 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs536631 | chr4:130065648-130065649 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs187816900 | chr4:130065653-130065654 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs115475752 | chr4:130065685-130065686 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs572335677 | chr4:130065796-130065797 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs554653749 | chr4:130065928-130065929 | Enhancers Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs572852487 | chr4:130065954-130065955 | Enhancers Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192323789 | chr4:130065976-130065977 | Enhancers Active TSS Bivalent Enhancer Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34758565 | chr4:130066043-130066044 | Enhancers Active TSS Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12505162 | chr4:130066104-130066105 | Enhancers Active TSS Bivalent Enhancer Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs374907482 | chr4:130066126-130066127 | Enhancers Active TSS Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369340076 | chr4:130066127-130066128 | Enhancers Active TSS Bivalent Enhancer Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs72928002 | chr4:130066204-130066205 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs183624352 | chr4:130066230-130066231 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs562661619 | chr4:130066237-130066238 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Developmental delay | 21147756 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Gastric cancer | 16891809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:130060200-130065800 | Weak transcription | K562 | blood |
2 | chr4:130060400-130065800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr4:130060400-130066000 | Weak transcription | Pancreas | Pancrea |
4 | chr4:130063200-130065800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr4:130065800-130066000 | Active TSS | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr4:130065800-130066200 | Active TSS | Adipose Nuclei | Adipose |
7 | chr4:130065800-130066200 | Bivalent Enhancer | Left Ventricle | heart |
8 | chr4:130065800-130066200 | Enhancers | HUVEC | blood vessel |
9 | chr4:130065800-130066200 | Flanking Active TSS | K562 | blood |
10 | chr4:130065800-130066400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr4:130065800-130066800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr4:130066000-130066400 | Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr4:130066200-130067200 | Active TSS | K562 | blood |
14 | chr4:130066400-130066600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr4:130066400-130067000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
16 | chr4:130066600-130066800 | Flanking Bivalent TSS/Enh | HepG2 | liver |
17 | chr4:130066600-130067000 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
18 | chr4:130067200-130068000 | Enhancers | K562 | blood |